The Queen's Health System

COVID-19
Care Center

Mon. – Fri.: 7:30 a.m. – 5:00 p.m.
Saturday 8:00 a.m. – 2:00 p.m.

Mon. – Fri.: 7:00 a.m. – 7:00 p.m.
Sat. – Sun.: 7:00 a.m. – 3:30 p.m.

COVID-19 Home

COVID Testing

Vaccine Clinics

Pfizer Vaccine FAQ

Moderna Vaccine FAQ

Janssen Vaccine FAQ

Visitor Guidance

Post COVID Care Clinic

Telehealth

Vaccination Clinics

For the safety and well-being of all, please do not come to our vaccine clinics if you have been diagnosed with COVID-19 in the last 20 days and/or have symptoms of COVID-19 (cough, fever, muscle aches, fatigue, trouble breathing, headache, etc…).

Oahu Locations

Location: 1329 Lusitana Street, Suite 203

ADA accommodations available

Days/Hours of Operation:  Monday-Saturday, 6:45 a.m. – 6:20 p.m., closed 12:00-1:00 p.m. for lunch, closed Sunday

Parking: No charge for the first hour.  $3 for second hour. 

Eligibility: Individuals 5 years old & older (WALK-INS WELCOME)


AVAILABLE APPOINTMENTS (5+ YEARS OLD):

1st Dose
If you have not been vaccinated

3rd/4th Dose
For immunocompromised individuals only. Third dose for Moderna & Pfizer vaccine must be at least 28 days after the second dose (Pfizer vaccine eligible to those 5+years old).  Fourth dose may be given at least five (5) months after third dose.

Additional dose of mRNA vaccine can be given 28 days after first dose of Johnson & Johnson.  A booster dose of mRNA vaccine may be given at least two months after additional dose.

2nd Booster Dose

  • A second booster dose of the Pfizer-BioNTech COVID-19 vaccine or Moderna COVID-19 vaccine may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine
  • A second booster dose of the Pfizer-BioNTech COVID-19 vaccine may be administered to individuals 12 years of age and older with certain kinds of immunocompromise at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine. These are people who have undergone solid organ transplantation, or who are living with conditions that are considered to have an equivalent level of immunocompromise
  • A second booster dose of the Moderna COVID-19 vaccine may be administered at least 4 months after the first booster dose of any authorized or approved COVID-19 vaccine to individuals 18 years of age and older with the same certain kinds of immunocompromise

1st Booster Dose

  • A first booster dose of the Pfizer-BioNTech COVID-19 vaccine may be administered to individuals 5-11 years of age at least five (5) months after receipt of the primary vaccine series of the Pfizer-BioNTech COVID-19 vaccine
  • A first booster may be received if you have received two (2) doses of the Pfizer/Moderna vaccine and it is at least five (5) months from your second dose of the Pfizer or Moderna vaccine.
  • You have received one (1) dose of the Johnson & Johnson vaccine at least two (2) months ago. 

***The use of the available COVID-19 vaccines as a “mix and match” for a booster dose is allowed for eligible individuals.


PREPARE FOR APPOINTMENT

 

Location:  1215 Hunakai Street

ADA accommodations available

Days/Hours of Operation:  Monday-Saturday 8:00 a.m.-7:45 p.m., closed 12:00-1:00 p.m. for lunch, closed Sunday

Parking: No charge

Eligibility: Individuals 5 years old & older (WALK-INS WELCOME)


AVAILABLE APPOINTMENTS (5+ YEARS OLD):

1st Dose
If you have not been vaccinated

3rd/4th Dose
For immunocompromised individuals only. Third dose for Moderna & Pfizer vaccine must be at least 28 days after the second dose (Pfizer vaccine eligible to those 5+years old).  Fourth dose may be given at least five (5) months after third dose.

Additional dose of mRNA vaccine can be given 28 days after first dose of Johnson & Johnson.  A booster dose of mRNA vaccine may be given at least two months after additional dose.

2nd Booster Dose

  • A second booster dose of the Pfizer-BioNTech COVID-19 vaccine or Moderna COVID-19 vaccine may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine
  • A second booster dose of the Pfizer-BioNTech COVID-19 vaccine may be administered to individuals 12 years of age and older with certain kinds of immunocompromise at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine. These are people who have undergone solid organ transplantation, or who are living with conditions that are considered to have an equivalent level of immunocompromise
  • A second booster dose of the Moderna COVID-19 vaccine may be administered at least 4 months after the first booster dose of any authorized or approved COVID-19 vaccine to individuals 18 years of age and older with the same certain kinds of immunocompromise

1st Booster Dose

  • A first booster dose of the Pfizer-BioNTech COVID-19 vaccine may be administered to individuals 5-11 years of age at least five (5) months after receipt of the primary vaccine series of the Pfizer-BioNTech COVID-19 vaccine
  • A first booster may be received if you have received two (2) doses of the Pfizer/Moderna vaccine and it is at least five (5) months from your second dose of the Pfizer or Moderna vaccine.
  • You have received one (1) dose of the Johnson & Johnson vaccine at least two (2) months ago. 

***The use of the available COVID-19 vaccines as a “mix and match” for a booster dose is allowed for eligible individuals.


PREPARE FOR APPOINTMENT

 

Location:  91-6390 Kapolei Parkway (corner of Kapolei Parkway & Keone’ula Boulevard)

ADA accomodations available

Days/Hours of Operation:  Monday-Friday 1:00 p.m.-7:30 p.m.

Parking:  No charge

Eligibility:  Individuals 5 years old & older (WALK INS WELCOME)


AVAILABLE APPOINTMENTS (5+ YEARS OLD):

1st Dose
If you have not been vaccinated

3rd/4th Dose
For immunocompromised individuals only. Third dose for Moderna & Pfizer vaccine must be at least 28 days after the second dose (Pfizer vaccine eligible to those 5+years old).  Fourth dose may be given at least five (5) months after third dose.

Additional dose of mRNA vaccine can be given 28 days after first dose of Johnson & Johnson.  A booster dose of mRNA vaccine may be given at least two months after additional dose.

2nd Booster Dose

  • A second booster dose of the Pfizer-BioNTech COVID-19 vaccine or Moderna COVID-19 vaccine may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine
  • A second booster dose of the Pfizer-BioNTech COVID-19 vaccine may be administered to individuals 12 years of age and older with certain kinds of immunocompromise at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine. These are people who have undergone solid organ transplantation, or who are living with conditions that are considered to have an equivalent level of immunocompromise
  • A second booster dose of the Moderna COVID-19 vaccine may be administered at least 4 months after the first booster dose of any authorized or approved COVID-19 vaccine to individuals 18 years of age and older with the same certain kinds of immunocompromise

1st Booster Dose

  • A first booster dose of the Pfizer-BioNTech COVID-19 vaccine may be administered to individuals 5-11 years of age at least five (5) months after receipt of the primary vaccine series of the Pfizer-BioNTech COVID-19 vaccine
  • A first booster may be received if you have received two (2) doses of the Pfizer/Moderna vaccine and it is at least five (5) months from your second dose of the Pfizer or Moderna vaccine.
  • You have received one (1) dose of the Johnson & Johnson vaccine at least two (2) months ago. 

***The use of the available COVID-19 vaccines as a “mix and match” for a booster dose is allowed for eligible individuals.


PREPARE FOR APPOINTMENT

Eligibility: Individuals 18 years old & older

You will be receiving the Johnson & Johnson/Janssen COVID-19 vaccine.  

Schedule Vaccine Appointment

Neighbor Island Locations

Queen’s North Hawai’i Community Hospital on the Big Island is offering the Pfizer vaccination for those age five and over. Anyone under 18 must be accompanied by a parent or legal guardian. 

The QNHCH Vaccination Clinic is open on Wednesdays ONLY.

Vaccinations for anyone age 5 and over                        11:00 a.m. – 3:00 p.m. 

Location:  Employee Health Annex

  • Those under 18 must be accompanied by a parent or legal guardian
  • Masks and physical distancing required
  • Please bring photo ID and insurance card (if you have one)
  • Avoid wearing long-sleeved clothing
  • No children not receiving a vaccination allowed
  • No animals allowed

3rd/4th Dose
For immunocompromised individuals only. Third dose for Moderna & Pfizer vaccine must be at least 28 days after the second dose (Pfizer vaccine eligible to those 5+years old).  Fourth dose may be given at least five (5) months after third dose.

Additional dose of mRNA vaccine can be given 28 days after first dose of Johnson & Johnson.  A booster dose of mRNA vaccine may be given at least two months after additional dose.

2nd Booster Dose

  • A second booster dose of the Pfizer-BioNTech COVID-19 vaccine or Moderna COVID-19 vaccine may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine
  • A second booster dose of the Pfizer-BioNTech COVID-19 vaccine may be administered to individuals 12 years of age and older with certain kinds of immunocompromise at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine. These are people who have undergone solid organ transplantation, or who are living with conditions that are considered to have an equivalent level of immunocompromise
  • A second booster dose of the Moderna COVID-19 vaccine may be administered at least 4 months after the first booster dose of any authorized or approved COVID-19 vaccine to individuals 18 years of age and older with the same certain kinds of immunocompromise

1st Booster Dose

  • A first booster may be received if you have received two (2) doses of the Pfizer/Moderna vaccine and it is at least five (5) months from your second dose of the Pfizer or Moderna vaccine.
  • You have received one (1) dose of the Johnson & Johnson vaccine at least two (2) months ago. 

***The use of the available COVID-19 vaccines as a “mix and match” for a booster dose is allowed for eligible individuals.

Prepare for Your Vaccination 

  • The entire vaccination process may take about 45 minutes to 1 hour (this includes a 15-minute monitoring period)
  • To speed up the process, please consider bringing both the Patient Registration Form and the Pre-Vaccination Questionnaire with you (see links below)

Downloads:
Patient Registration Form

Pre-Vaccination Questionnaire

Pfizer COVID-19 Vaccine Fact Sheet

Moderna COVID-19 Vaccine Fact Sheet

Pfizer COVID-19 Vaccine Fact Sheet (5-11 years old)

COVID-19 VACCINE AVAILABLE FOR:

  • All Molokai residents ages 5 years old & older
  • Where: Molokai General Hospital, 280 Home Olu Place
  • Pfizer, Moderna, and Johnson & Johnson vaccine offered

Vaccinations are by appointment only.

Please call 808-553-3121, ext 0 to schedule an appointment. 

Monday through Friday, 10:00 am – 5:00 pm

  • For individuals with Medicare, please bring your red, white, and blue Medicare card with you
  • For up-to-date information on future clinics, please go to Molokai General Hospital’s Facebook page or molokaigeneralhospital.org
  • Please bring your COVID-19 vaccination card, ID, and Insurance Cards

3rd/4th Dose
For immunocompromised individuals only. Third dose for Moderna & Pfizer vaccine must be at least 28 days after the second dose (Pfizer vaccine eligible to those 5+years old).  Fourth dose may be given at least five (5) months after third dose.

Additional dose of mRNA vaccine can be given 28 days after first dose of Johnson & Johnson.  A booster dose of mRNA vaccine may be given at least two months after additional dose.

2nd Booster Dose

  • A second booster dose of the Pfizer-BioNTech COVID-19 vaccine or Moderna COVID-19 vaccine may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine
  • A second booster dose of the Pfizer-BioNTech COVID-19 vaccine may be administered to individuals 12 years of age and older with certain kinds of immunocompromise at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine. These are people who have undergone solid organ transplantation, or who are living with conditions that are considered to have an equivalent level of immunocompromise
  • A second booster dose of the Moderna COVID-19 vaccine may be administered at least 4 months after the first booster dose of any authorized or approved COVID-19 vaccine to individuals 18 years of age and older with the same certain kinds of immunocompromise

1st Booster Dose

  • A first booster may be received if you have received two (2) doses of the Pfizer/Moderna vaccine and it is at least five (5) months from your second dose of the Pfizer or Moderna vaccine.
  • You have received one (1) dose of the Johnson & Johnson vaccine at least two (2) months ago. 

***The use of the available COVID-19 vaccines as a “mix and match” for a booster dose is allowed for eligible individuals.


Downloads

Pre-Vaccination Questionnaire

Moderna COVID-19 Vaccine Fact Sheet

Pfizer COVID-19 Vaccine Fact Sheet

Pfizer COVID-19 Vaccine Fact Sheet (5-11 years old)

Vaccine Appointments

Cancelling your Appointment

Rescheduling your Appointment

  • Please contact our COVID-19 Vaccination Line at 808-691-2222

 

Mobile Locations

Pre-Vaccination Questionnaire

Moderna COVID-19 Vaccine Fact Sheet

Pfizer COVID-19 Vaccine Fact Sheet

Pfizer COVID-19 Vaccine Fact Sheet (5-11 years old)

Janssen COVID-19 Vaccine Fact Sheet

FAQs

The Centers for Disease Control (CDC) strongly recommends you get vaccinated. The vaccine will help protect you from getting COVID-19. If you still get infected after you get vaccinated, the vaccine may prevent serious illness. By getting vaccinated, you can also help protect people around you.

No. None of the COVID-19 vaccines currently authorized for use or in development in the United States use the live virus that causes COVID-19. However, it typically takes a few weeks for the body to build immunity after vaccination. That means it is possible you could be infected with the virus that causes COVID-19 just before or just after vaccination and get sick.

Yes. The CDC recommends you get vaccinated even if you have already had COVID-19 because you can catch it more than once. While you may have some short-term antibody protection after recovering from COVID-19, we don’t know how long this protection will last.

Yes, with updated published results, Pfizer has been given an Emergency Use Authorization by the U.S. FDA for children ages 5-17.

Yes. COVID-19 vaccination is especially important for people with underlying health problems like heart disease, lung disease, diabetes, and obesity. People with these conditions are more likely to get very sick from COVID-19.

No. While you may have some short-term antibody protection after recovering from COVID-19, we don’t know how long this protection lasts. Vaccination is the best protection, and it is safe. People who get COVID-19 can have serious illnesses, and some have debilitating symptoms that persist for months.

There may be side effects, but they should go away within a few days. Possible side effects include a sore arm, headache, fever, or body aches. This does not mean you have COVID-19. Side effects are signs that the vaccine is working to build immunity. If they don’t go away in a week, or you have more serious symptoms, call your doctor.

Because all COVID-19 vaccines are new, it will take more time and more people getting vaccinated to learn about very rare or possible long-term side effects. At least 8 weeks’ worth of safety data were gathered in the clinical trials for all the authorized vaccines, and it is unusual for vaccine side effects to appear more than 8 weeks after vaccination.

All COVID-19 vaccines were tested in clinical trials involving tens of thousands of people to make sure they meet safety standards and protect adults of different ages, races, and ethnicities. There were no serious safety concerns. The CDC and the FDA will keep monitoring the vaccines to look for safety issues after they are authorized and in use.

People with HIV infection, other immunocompromising conditions, or who take immunosuppressive medications or therapies might be at an increased risk for severe COVID-19.  Data is not currently available to establish safety and efficacy of the vaccine in these groups.  These individuals may still receive the COVID-19 vaccine unless otherwise contraindicated.  Individuals should be counseled about: unknown vaccine safety and efficacy profiles in immunocompromised persons, potential for reduced immune responses, need to continue to follow all current guidance to protect themselves against COVID-19.

There is no data on the safety of the COVID-19 vaccine in pregnant women.  Studies are ongoing and more are planned.  If a woman is part of a group (e.g., healthcare personnel) who is recommended to receive a COVID-19 vaccine and is pregnant, she may choose to be vaccinated. A discussion with her healthcare provider can help her make an informed decision. Considerations for vaccination: level of COVID-19 community transmission, risk of acquisition – her personal risk of contracting COVID-19 (by occupation or other activities), the risks of COVID-19 to her and potential risks to the fetus, the efficacy of the vaccine, the known side effects of the vaccine, the lack of data about the vaccine during pregnancy.

There is no data on the safety of COVID-19 vaccines in lactating women or the effects of mRNA vaccines on the breastfed infant or milk production/excretion.  mRNA vaccines are not considered live virus vaccines and are not thought to be a risk to the breastfeeding infant.  If a lactating woman is part of a group (e.g., healthcare personnel) who is recommended to receive a COVID-19 vaccine, she may choose to be vaccinated.

All recipients who receive the vaccine are encouraged to enroll in v-safe https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/vsafe.html.  This is a smartphone tool you can use to tell the CDC if you have any side effects after getting a COVID-19 vaccine. If you report serious side effects, someone from the CDC will call to follow up.

Additional Resources

If you received a vaccination at any of the clinics operated by The Queen’s Health Systems please call 808-691-1291 to request a replacement card.  You can also email [email protected].


 View translated resources in your language. Click Here.